Phivi Rondogianni

Role of [18F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer

Evangelia Skoura, Phivi Rondogianni, Maria Alevizaki et al. · Nuclear Medicine Communications · 2010 · 38 citations

Medicine, Nuclear Medicine, Radiology +17

Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.

Dimitrios Krikelis, Evangelia Skoura, Vassiliki Kotoula et al. · PubMed · 2014 · 37 citations

Medicine, Molecular Medicine, Oncology +17

Interobserver variability, and visual and quantitative parameters of 123I-FP-CIT SPECT (DaTSCAN) studies

Phivi Rondogianni, Panagiota Chroni, Marios Themistocleous et al. · Annals of Nuclear Medicine · 2012 · 36 citations

Medicine, Nuclear Medicine, Radiology +5

Correlation between Calcitonin Levels and [<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mtext>F</mml:mtext><mml:mrow><mml:mn mathvariant="bold">18</mml:mn></mml:mrow></mml:mrow></mml:math>]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid Cancer

Evangelia Skoura, Ioannis Datseris, Phivi Rondogianni et al. · ISRN Endocrinology · 2012 · 26 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, Maria K. Angelopoulou et al. · Annals of Hematology · 2021 · 26 citations

Medicine, Nuclear Medicine, Oncology +16